IRCT20180620040164N55招募中Unknown
Comparative bioequivalence study of Finasteride 5 mg Tablet of Karen Pharma and Food Supplement Co. and PROSCAR® of ORGANON as reference in 24 healthy male under fasting.
Iran Hormone Pharmaceutical Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 45 years（—）
- 性别
- Male
入选标准
- •Healthy subjects (male) between 20 – 45 years of age.
- •Body Mass Index (BMI) within 15% of normal range according to the accepted normal values between 18.5 and 30 (inclusive), calculated as kg/m2.
排除标准
- •Subjects with known allergy to Tested Product.
- •Subjects with no significant diseases or clinically significant abnormal findings during screening, medical history, clinical examination and laboratory evaluations.
- •Smoking more than 10 cigarettes per day and could not tolerate cigarette cessation during each clinical period.
- •A history of difficulty with donating blood or donation of more than 500 ml blood within 7 days prior to the start of the study.
- •Married candidates are advised to strictly refrain from sexual intercourse during the test and in the sampling interval.
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence Test ofFinasteride tablets with brand drug (PROSCAR® 5 mg, FC. Tablets, MSD,Germany)IRCT20200105046010N54Aburayhan Pharmaceutical Company24
招募中
3 期
Comparative efficacy study of topical finasteride in androgenic alopeciaIRCT20191203045592N2Esfahan University of Medical Sciences40
已完成
1 期
Finasteride 5 mg Tablets Under Fasting ConditionsHealthyNCT00835666Teva Pharmaceuticals USA32
已完成
1 期
Finasteride 5 mg Tablets, Non-fastingHealthyNCT00835796Teva Pharmaceuticals USA20
已完成
3 期
Effect of finasterid on COVID-19 treatmentCorona virus pneumonia.COVID-19,virus not identifiedU07.2IRCT20200505047318N1Qazvin University of Medical Sciences80